Fig. 5
From: FoXA2 promotes esophageal squamous cell carcinoma progression by ZEB2 activation
Silence of ZEB2 reversed the inhibitory effect of si-FOXA2#1 on ESCC progression. A Cell viability was measured in ECA109 and YESE-140 cells transfection with si-FOXA2#1 or combined with si-ZEB2. B Cell migration was measured in ECA109 and YESE-140 cells transfection with si-FOXA2#1, or combined with si-ZEB2. C Cell invasion was detected in ECA109 and YESE-140 cells transfection with si-FOXA2#1, or combined with si-ZEB2. *P < 0.05, **P < 0.01; #P < 0.05